Rancho Cucamonga, CA1 Active Studies

Ankylosing Spondylitis Clinical Trials in Rancho Cucamonga, CA

Find 1 actively recruiting ankylosing spondylitis clinical trials in Rancho Cucamonga, CA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
124
Enrolling

Recruiting Ankylosing Spondylitis Studies in Rancho Cucamonga

About Ankylosing Spondylitis Clinical Trials in Rancho Cucamonga

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 1 ankylosing spondylitis clinical trials recruiting participants in Rancho Cucamonga, CA. These studies are seeking a combined 124 participants. Research is being sponsored by Uniquity One (UNI). Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Rancho Cucamonga — FAQ

Are there ankylosing spondylitis clinical trials in Rancho Cucamonga?

Yes, there are 1 ankylosing spondylitis clinical trials currently recruiting in Rancho Cucamonga, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Rancho Cucamonga?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Rancho Cucamonga research site will contact you about next steps.

Are clinical trials in Rancho Cucamonga free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Rancho Cucamonga studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 1 active trials in Rancho Cucamonga are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov